Sodium-glucose co-transporter 2 inhibitor use was associated with significantly lower risks for diabetic retinopathy compared with the use of dipeptidyl peptidase-4 inhibitors, sulfonylureas, and pioglitazone. Sodium-glucose cotransporter 2 (SGLT2) inhibitors may reduce the risk of severe diabetic retinopathy threatening patients’ vision.
SGLT2 Inhibitors May Offer Better Protection Against Diabetic Retinopathy empr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from empr.com Daily Mail and Mail on Sunday newspapers.
Sodium-glucose co-transporter 2 inhibitor use was associated with significantly lower risks for diabetic retinopathy compared with the use of dipeptidyl peptidase-4 inhibitors, sulfonylureas, and pioglitazone. Sodium-glucose cotransporter 2 (SGLT2) inhibitors may reduce the risk of severe diabetic retinopathy threatening patients’ vision.
Hydroxychloroquine use predicts lower risk for fatty liver disease in rheumatoid arthritis healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
1. In a large Taiwanese cohort, it was found that patients with hyperlipidemia had higher risk of developing stenosing tenosynovitis, otherwise known as trigger finger, compared to controls. Trigger finger, also referred to as stenosing tenosynovitis, is a common condition in those aged 50 to 60 years. The disease is characterized by pain and locking